Franklin Genomic Advancements ETF Rating $30.33 -0.04 (-0.13%) (As of 12/17/2024 ET) Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatings Franklin Genomic Advancements ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HELX Aggregate RatingModerate Buy 2.74Holdings in HELX have an aggregate rating of Moderate Buy based on 658 analyst ratings issued in the past year covering 46 companies (88.4% of the portfolio).HELX Aggregate Price Target$30.33High Prediction$30.33Average Prediction$30.33Low Prediction$30.33Holdings in HELX have an aggregate price target of $30.33 and a range of $30.33 to $30.33 covering 46 companies (88.4% of the portfolio).HELX Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy5 Buy rating(s)Moderate Buy33 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Franklin Genomic Advancements ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 46 HELX Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.81%NTRANatera$168.21-1.5%2.1255 of 5 stars3.00$152.67 -9.2%155.52%VRTXVertex Pharmaceuticals$469.24+0.2%4.2083 of 5 stars2.55$505.73 7.8%31Analyst ForecastPositive News4.61%LLYEli Lilly and Company$778.30-0.1%4.9951 of 5 stars2.81$1,002.22 28.8%21Buyback Announcement4.59%KRYSKrystal Biotech$169.04+0.9%4.3121 of 5 stars3.00$206.67 22.3%8Analyst Forecast4.01%REGNRegeneron Pharmaceuticals$740.01+2.1%4.7088 of 5 stars2.70$1,052.90 42.3%23Analyst Forecast3.90%MEDPMedpace$348.48-0.4%4.381 of 5 stars2.45$380.56 9.2%113.87%TMOThermo Fisher Scientific$528.71-0.3%4.8621 of 5 stars2.86$652.30 23.4%21Analyst RevisionPositive News3.78%DHRDanaher$233.53-0.3%4.8508 of 5 stars2.79$287.95 23.3%19Short Interest ↑Analyst Revision2.50%UTHRUnited Therapeutics$379.69+1.8%4.7106 of 5 stars2.73$370.86 -2.3%15Positive News2.50%BNTXBioNTech$117.39+2.8%2.3177 of 5 stars2.82$140.76 19.9%172.41%AZNAstraZeneca$67.18+1.4%4.2204 of 5 stars2.91$89.75 33.6%11Short Interest ↓2.38%CDNSCadence Design Systems$311.35-0.7%4.4588 of 5 stars2.77$327.92 5.3%13Insider TradePositive News2.36%CTVACorteva$58.57-0.6%4.6031 of 5 stars2.68$65.06 11.1%192.21%INSMInsmed$73.85+0.6%3.1781 of 5 stars3.00$83.67 13.3%16Positive News2.19%AAgilent Technologies$136.46-0.9%4.7544 of 5 stars2.43$143.62 5.2%14Short Interest ↓Analyst Revision2.09%IONSIonis Pharmaceuticals$37.68-1.1%4.4692 of 5 stars2.68$60.65 61.0%19Short Interest ↓Positive News2.02%BRKRBruker$57.81+1.1%4.9938 of 5 stars2.55$74.70 29.2%11Short Interest ↑1.95%CRLCharles River Laboratories International$189.39-0.4%4.6334 of 5 stars1.93$214.00 13.0%15Positive News1.94%QGENQiagen$45.34-0.1%4.2311 of 5 stars2.60$51.15 12.8%101.92%RVTYRevvity$114.75-0.4%3.9598 of 5 stars2.75$132.47 15.4%16Positive News1.86%ALNYAlnylam Pharmaceuticals$246.58+1.1%4.5509 of 5 stars2.71$298.09 20.9%24Short Interest ↓1.65%SRPTSarepta Therapeutics$125.76-0.8%4.9058 of 5 stars2.91$178.71 42.1%22Insider TradePositive News1.48%RAREUltragenyx Pharmaceutical$44.95-1.0%4.5695 of 5 stars2.92$87.46 94.6%131.47%EXASExact Sciences$60.37-0.6%4.6099 of 5 stars2.94$72.94 20.8%181.46%TWSTTwist Bioscience$48.40-0.1%3.0264 of 5 stars2.70$51.90 7.2%101.30%LGNDLigand Pharmaceuticals$120.43-1.6%4.8863 of 5 stars3.00$147.00 22.1%6Analyst ForecastAnalyst RevisionNews Coverage1.26%ICLRICON Public$203.26-0.5%4.2968 of 5 stars2.85$290.20 42.8%131.22%RCKTRocket Pharmaceuticals$11.92+1.4%4.8536 of 5 stars2.91$51.00 327.9%11Analyst ForecastAnalyst Revision1.08%LHLaboratory Co. of America$230.95+0.6%4.9736 of 5 stars2.81$258.62 12.0%16Analyst ForecastPositive News1.07%RGENRepligen$158.14-1.7%3.7685 of 5 stars2.62$185.20 17.1%13Analyst ForecastAnalyst RevisionPositive News1.04%BBIOBridgeBio Pharma$27.82+0.4%4.7227 of 5 stars2.86$47.69 71.4%14Analyst Forecast1.01%IQVIQVIA$196.64-0.2%4.9237 of 5 stars2.90$256.19 30.3%20Short Interest ↓Analyst Revision1.00%TECHBio-Techne$75.27-1.2%4.3205 of 5 stars2.63$82.00 8.9%8Short Interest ↑Positive News0.97%BEAMBeam Therapeutics$28.58-1.2%3.3722 of 5 stars2.82$47.67 66.8%11Short Interest ↓0.93%NBIXNeurocrine Biosciences$136.69+2.7%4.8855 of 5 stars2.83$166.00 21.4%23Analyst ForecastPositive News0.92%VYGRVoyager Therapeutics$6.25-3.5%4.6573 of 5 stars3.11$17.00 172.0%90.92%AZTAAzenta$46.31+4.1%3.5585 of 5 stars2.60$61.60 33.0%5Positive News0.72%RXRXRecursion Pharmaceuticals$7.12-4.3%2.5354 of 5 stars2.40$9.25 29.9%5High Trading Volume0.69%TEMTempus AI$38.95-2.3%2.8585 of 5 stars2.75$56.00 43.8%12High Trading Volume0.66%MRNAModerna$40.76-2.6%4.4064 of 5 stars2.14$79.50 95.0%210.64%VCYTVeracyte$42.24-2.5%4.178 of 5 stars2.67$41.13 -2.6%9Positive News0.52%BIOBio-Rad Laboratories$337.28-1.7%4.4475 of 5 stars2.60$394.20 16.9%5Short Interest ↓Positive News0.51%CDMOAvid Bioservices$12.362.5177 of 5 stars2.00$12.25 -0.9%40.51%CRSPCRISPR Therapeutics$44.63+0.9%1.8913 of 5 stars2.44$77.93 74.6%18Short Interest ↓0.50%DVAXDynavax Technologies$12.90+0.4%4.8018 of 5 stars2.67$22.00 70.5%3News CoveragePositive News0.48%DOCSDoximity$52.71-1.1%3.0858 of 5 stars2.42$52.44 -0.5%19Positive News This page (BATS:HELX) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Franklin Genomic Advancements ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Franklin Genomic Advancements ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HELX Stock Alerts